ChemoCentryx’s Avacopan May Need Another Trial After Tepid Advisory Committee Vote

 
• By Sarah Karlin-Smith
  
ChemoCentryx’s avacopan may need a second Phase III trial to get FDA approval.
Pink Sheet Podcast

Have you checked out Pink Sheet podcast?

New episodes every Thursday.

SpotifyApple PodcastsWebsite

More from US FDA Performance Tracker

More from Regulatory Trackers